ESPR·29664W105·US·equity·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G
ESPR (ESPERION THERAPEUTICS INC) is held by 104 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($48.9M), WASATCH ADVISORS LP ($43.2M), TWO SIGMA INVESTMENTS, LP ($25.9M). Net institutional sentiment: Mixed.
See how ESPR's score breaks down across 4 SEC sources
Showing 1-20 of 116
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer